Opportunities to improve drug discovery systems

<div style="font-weight: 400;"> <p><span data-contrast="none">This is the latest episode of the free DDW podcast: “</span><span data-contrast="none">Opportunities to improve drug discovery systems</span><span data-contrast= "none">”. It covers two articles written for Volume 22, Issue 1 – Winter 2020/21 of the Drug Discovery World Magazine. </span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> </div> <div style="font-weight: 400;"> <p><span data-contrast="none">The first article is titled “Precision control of protein release to reconfigure bioprocessing and cell-based assays”, where the authors Dr J. Mark Treherne, Dr Christian Pernstich and Dr Michael Jones examine how the controlled release of proteins will improve the reproducibility of cell-based drug discovery screens.</span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> </div> <div style="font-weight: 400;"> <p><span data-contrast="none">The second is called “Boosting pharmaceutical research with microbiome data”, where Anthony Finbow, CEO of Eagle Genomics, reports how microbiome-based evidence is set to drive understanding of how drugs interact with human ‘host’ environments, helping devise more targeted treatments and create business opportunities.</span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> </div>